Explore Watchlists Pricing

SAWAI GROUP HOLDINGS Co., Ltd. (4887) Balance sheet

Market cap

¥215.3B

P/E ratio

10.2x

Sawai Group Holdings manufactures and sells prescription and over-the-counter pharmaceuticals through its domestic subsidiaries in Japan.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	54,269	47,717	33,076	26,368	38,785	28,989
Marketable securities, current	-	146	179	167	2,480	348
Inventories	-	85,853	101,805	100,002	109,867	117,607
Total current assets	-	202,123	205,347	239,985	200,823	200,345
Property, plant and equipment, net	-	111,218	121,330	103,400	111,876	115,633
Marketable securities, non-current	-	7,223	7,791	8,779	4,134	4,593
Total non-current assets	-	147,379	158,818	142,039	153,800	159,574
Total assets	-	349,502	364,165	382,024	354,623	359,919
Short-term debt	-	4,419	4,444	16,049	21,503	14,675
Long-term debt, current	-	13,116	13,034	-	4,346	-
Total current liabilities	-	88,840	85,154	93,618	102,815	80,934
Long-term debt, non-current	-	56,522	62,590	69,699	77,292	99,633
Total non-current liabilities	-	60,579	66,272	70,375	77,954	100,429
Total liabilities	-	149,419	151,426	163,993	180,769	181,363
Retained earnings	-	98,709	141,642	149,645	157,257	161,589
Stockholders' equity	240,750	200,083	212,738	218,030	173,854	178,556